🇺🇸 FDA
Patent

US 11077178

Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use

granted A61KA61K2239/48A61K31/675

Quick answer

US patent 11077178 (Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2239/48, A61K31/675, A61K31/7076, A61K40/11